Group 1 - Arcadium reported quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.04 per share, representing a 75% earnings surprise [1] - The company posted revenues of $289 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 11.97%, compared to year-ago revenues of $181.8 million [2] - Over the last four quarters, Arcadium has surpassed consensus EPS estimates just once and topped consensus revenue estimates two times [2] Group 2 - The stock has gained approximately 13.7% since the beginning of the year, outperforming the S&P 500's gain of 1.3% [3] - The current consensus EPS estimate for the coming quarter is $0.04 on revenues of $282.4 million, and for the current fiscal year, it is $0.22 on revenues of $1.24 billion [7] - The Zacks Industry Rank for Chemical - Specialty is currently in the bottom 23% of over 250 Zacks industries, indicating potential challenges for stock performance [8]
Arcadium (ALTM) Lags Q4 Earnings Estimates